Difficulty: Medium
Average Score: 77%
Practice
Which component of sulfasalazine is responsible for the therapeutic effect in rheumatoid arthritis?
Correct answer
A
Rationale
In the context of pharmacology, understanding the mechanism of action of drugs is crucial for effective clinical practice. In the case of sulfasalazine, which is commonly used to treat rheumatoid arthritis, the therapeutic effect is primarily attributed to its metabolite sulfapyridine.
The correct answer, A) Sulfapyridine, is responsible for the anti-inflammatory and immunomodulatory effects seen in rheumatoid arthritis. Sulfapyridine is formed when sulfasalazine is broken down by colonic bacteria in the gastrointestinal tract. This metabolite inhibits the production of inflammatory mediators, such as prostaglandins, thereby reducing inflammation and providing relief to patients with rheumatoid arthritis.
Option B) 5-aminosalicylic acid is another metabolite of sulfasalazine, but it is primarily responsible for the treatment of inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It does not play a significant role in the treatment of rheumatoid arthritis.
Option D) Intact sulfasalazine molecule itself does not contribute directly to the therapeutic effect in rheumatoid arthritis. Its metabolites, particularly sulfapyridine, are the active agents responsible for the desired pharmacological actions.
Understanding the specific mechanisms of drug actions and their metabolites is essential for healthcare professionals to make informed decisions regarding drug selection and patient care. This knowledge helps in optimizing therapeutic outcomes and minimizing adverse effects for patients receiving pharmacological interventions.
The correct answer, A) Sulfapyridine, is responsible for the anti-inflammatory and immunomodulatory effects seen in rheumatoid arthritis. Sulfapyridine is formed when sulfasalazine is broken down by colonic bacteria in the gastrointestinal tract. This metabolite inhibits the production of inflammatory mediators, such as prostaglandins, thereby reducing inflammation and providing relief to patients with rheumatoid arthritis.
Option B) 5-aminosalicylic acid is another metabolite of sulfasalazine, but it is primarily responsible for the treatment of inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It does not play a significant role in the treatment of rheumatoid arthritis.
Option D) Intact sulfasalazine molecule itself does not contribute directly to the therapeutic effect in rheumatoid arthritis. Its metabolites, particularly sulfapyridine, are the active agents responsible for the desired pharmacological actions.
Understanding the specific mechanisms of drug actions and their metabolites is essential for healthcare professionals to make informed decisions regarding drug selection and patient care. This knowledge helps in optimizing therapeutic outcomes and minimizing adverse effects for patients receiving pharmacological interventions.